Genotypes of vitamin K epoxide reductase, γ-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients
- 31 December 2007
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 120 (2), 181-186
- https://doi.org/10.1016/j.thromres.2006.09.007
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Innovation
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 27 references indexed in Scilit:
- Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarinThrombosis and Haemostasis, 2006
- Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosingBlood, 2005
- Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin DoseThe New England Journal of Medicine, 2005
- A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivityHuman Molecular Genetics, 2005
- Common VKORC1 and GGCX polymorphisms associated with warfarin doseThe Pharmacogenomics Journal, 2005
- The Inhibitory Effect of Calumenin on the Vitamin K-dependent γ-Carboxylation SystemPublished by Elsevier BV ,2004
- Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and γ-glutamyl carboxylase) gene variants with warfarin sensitivityBlood, 2004
- Identification of the gene for vitamin K epoxide reductaseNature, 2004
- Identification of Sequences within the γ-Carboxylase That Represent a Novel Contact Site with Vitamin K-dependent Proteins and That Are Required for ActivityPublished by Elsevier BV ,2001
- Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial FibrillationStroke, 2000